Stem Cell Manufacturing Market - Global Industry Analysis

Stem Cell Manufacturing Market- By Product (Consumables, Instrument, HSCs, MSCs, iPSCs, and ESCs), By Application (Clinical Research and Cell & Tissue Banking), By End User (Pharma & Biotech, Hospitals, and Tissue Bank), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 14-Jul-2021 Category: Biotechnology Report Format : PDF Pages: 124 Report Code: ZMR-6478 Status : Published

The global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.

Description

The global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028. The report offers assessment and analysis of the Stem Cell Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Stem Cell Manufacturing Market: Overview

Stem cells possess huge potential for developing new cell treatments for unfulfilled medical requirements. Moreover, key aim of producing cell-based products is to manufacture large amount of viable, healthy, and phenotypically as well as genotypically stable cells and production of stem cells is no exception to this. Apart from this, industry players focus on devising stem cell manufacturing processes in such a way that the latter must fulfill goals of producing large number of healthy as well as phenotypically & genotypically stable cells.  Moreover, stem cells, which are also referred as Mesenchymal stem cells, are isolated by utilizing classic methods like ficoll gradient centrifugation as well as consequent cell fraction plating. Apart from this, Mesenchymal stem cells are adherent and can be easily separated from other kind of cells in initial phase of cell isolation through cell attachment in 2D tissue cell culture flasks.

Additionally, stem cells are utilized in allogenic or autologous approaches for manufacturing a cell lot that can manufacture multiple cell-based product units. In autologous approach, stem cells are processed, harvested, and expanded and after that reintroduced into patients.  Apparently, use of autologous method results in enhancing manufacturing controls in regulated environment leading to huge production of stem cells along with cost reduction & improved purity of cell-based products.

Global Stem Cell Manufacturing Market

Stem Cell Manufacturing Market: Growth Dynamics

Humungous use of stem cells for treating myriad kind of ailments will steer growth of stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to therapeutic potential of stem cell-based products, and favorable laws supporting stem cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over assessment period. Rise in research activities in pharma & biotech industries will provide impetus to stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.

Furthermore, delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency and hence massive acceptance of risk-based model in pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for stem cell manufacturing industry over the years to come. In addition to this, stem cells are garnering immense popularity due to their major role in effective disease management & specialized research events such as genomic testing & personalized drugs. This, in turn, will help stem cell manufacturing business expand leaps & bounds during upcoming years.

Regional Landscape

North America Account Majorly Towards Overall Market Size By 2028

The growth of stem cell manufacturing market in North America Over forecast period is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size. Rise in cell treatment and gene therapies in the sub-continent will boost production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for growth of stem cell manufacturing business in sub-continent of North America. Presence of major participants in countries such as the U.S. and Canada will further enlarge regional market scope in upcoming years.

Competitive Landscape

Stem cell manufacturing industry share is highly fragmented due to presence of giant players & new entrants. With need to establish competitive advantage, players in the market are trying to launch new stem cell manufacturing processes. Few of key players profiled in the study and leveraging market growth are Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.   

The global Stem Cell Manufacturing Market is segmented as follows:

By End-User

  • Hospitals
  • Pharma & Biotech
  • Tissue Bank

By Application

  • Clinical Research
  • Cell & Tissue Banking

By Product

  • Consumables
  • Instrument
  • HSCs
  • MSCs
  • iPSCs
  • ESCs

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Stem Cell Manufacturing Market, 2018–2028(USD Billion)
    • 2.2. Stem Cell Manufacturing Market: Snapshot
  • Chapter 3. Global Stem Cell Manufacturing Market– End-User Analysis
    • 3.1. Stem Cell Manufacturing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Stem cells are garnering large-scale demand subject to their key rule in proficient disease management & specialized research events such as genomic testing & personalized drugs. This, in turn, will help stem cell manufacturing business expand leaps & bounds during upcoming years.
      • 3.2.2. Humungous use of stem cells for treating various types of ailments will embellish expansion of stem cell manufacturing market over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By End-User
      • 3.4.2. Market attractiveness analysis By Application
      • 3.4.3. Market attractiveness analysis By Product
  • Chapter 4. Global Stem Cell Manufacturing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Stem Cell Manufacturing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Stem Cell Manufacturing Market– End-User Analysis
    • 5.1. Global Stem Cell Manufacturing Market overview: By End-User
      • 5.1.1. Global Stem Cell Manufacturing Market share, By End-User , 2020 and 2028
    • 5.2. Hospitals
      • 5.2.1. Global Stem Cell Manufacturing Market by Hospitals, 2018–2028(USD Billion)
    • 5.3. Pharma & Biotech
      • 5.3.1. Global Stem Cell Manufacturing Market by Pharma & Biotech, 2018–2028(USD Billion)
    • 5.4. Tissue Bank
      • 5.4.1. Global Stem Cell Manufacturing Market by Tissue Bank, 2018–2028(USD Billion)
  • Chapter 6. Global Stem Cell Manufacturing Market– Application Analysis
    • 6.1. Global Stem Cell Manufacturing Market overview: By Application
      • 6.1.1. Global Stem Cell Manufacturing Market share, By Application, 2020 and 2028
    • 6.2. Clinical Research
      • 6.2.1. Global Stem Cell Manufacturing Market by Clinical Research, 2018–2028(USD Billion)
    • 6.3. Cell & Tissue Banking
      • 6.3.1. Global Stem Cell Manufacturing Market by Cell & Tissue Banking, 2018–2028(USD Billion)
  • Chapter 7. Global Stem Cell Manufacturing Market– Product Analysis
    • 7.1. Global Stem Cell Manufacturing Market overview: By Product
      • 7.1.1. Global Stem Cell Manufacturing Market share, By Product, 2020 and 2028
    • 7.2. Consumables
      • 7.2.1. Global Stem Cell Manufacturing Market by Consumables, 2018–2028(USD Billion)
    • 7.3. Instrument
      • 7.3.1. Global Stem Cell Manufacturing Market by Instrument, 2018–2028(USD Billion)
    • 7.4. ESCs
      • 7.4.1. Global Stem Cell Manufacturing Market by ESCs, 2018–2028(USD Billion)
    • 7.5. iPSCs
      • 7.5.1. Global Stem Cell Manufacturing Market by iPSCs, 2018–2028(USD Billion)
    • 7.6. MSCs
      • 7.6.1. Global Stem Cell Manufacturing Market by MSCs, 2018–2028(USD Billion)
    • 7.7. HSCs
      • 7.7.1. Global Stem Cell Manufacturing Market by HSCs, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Thermo Fisher Scientific, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Lonza Group AG
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Sartorius AG
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Merck Milliopore
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Danahar Corporation
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Stem Cell Manufacturing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Stem Cell Manufacturing Marketattractiveness, By End-User
6. Global Stem Cell Manufacturing Marketattractiveness, By Application
7. Global Stem Cell Manufacturing Marketattractiveness, By Product
8. Global Stem Cell Manufacturing Marketshare by End-User ,2020 and 2028 (USD Billion)
9. Global Stem Cell Manufacturing Marketby Hospitals, 2018–2028(USD Billion)
10. Global Stem Cell Manufacturing Marketby Pharma & Biotech, 2018–2028(USD Billion)
11. Global Stem Cell Manufacturing Marketby Tissue Bank, 2018–2028(USD Billion)
12. Global Stem Cell Manufacturing Marketshare by Application ,2020 and 2028 (USD Billion)
13. Global Stem Cell Manufacturing Marketby Clinical Research, 2018–2028(USD Billion)
14. Global Stem Cell Manufacturing Marketby Cell & Tissue Banking, 2018–2028(USD Billion)
15. Global Stem Cell Manufacturing Marketshare by Product ,2020 and 2028 (USD Billion)
16. Global Stem Cell Manufacturing Marketby Consumables, 2018–2028(USD Billion)
17. Global Stem Cell Manufacturing Marketby Instrument, 2018–2028(USD Billion)
18. Global Stem Cell Manufacturing Marketby HSCs, 2018–2028(USD Billion)
19. Global Stem Cell Manufacturing Marketby MSCs, 2018–2028(USD Billion)
20. Global Stem Cell Manufacturing Marketby iPSCs, 2018–2028(USD Billion)
21. Global Stem Cell Manufacturing Marketby ESCs, 2018–2028(USD Billion)
22. Global Stem Cell Manufacturing Marketshare, by Region, 2020 and 2028
23. North America Stem Cell Manufacturing Market, 2018–2028(USD Billion)
24. Europe Stem Cell Manufacturing Market, 2018–2028(USD Billion)
25. Asia Pacific Stem Cell Manufacturing Market, 2018–2028(USD Billion)
26. Latin America Stem Cell Manufacturing Market, 2018–2028(USD Billion)
27. The Middle East and Africa Stem Cell Manufacturing Market, 2018–2028(USD Billion)


Table Of Tables

List of Tables

1. Global Stem Cell Manufacturing Market: snapshot
2. Drivers of the Stem Cell Manufacturing Market: impact analysis
3. North America Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
4. North America Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
5. North America Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
6. The U.S. Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
7. The U.S. Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
8. The U.S. Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
9. Rest of North America Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
10. Rest of North America Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
11. Rest of North America Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
12. Europe Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
13. Europe Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
14. Europe Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
15. UK Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
16. UK Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
17. UK Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
18. France Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
19. France Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
20. France Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
21. Germany Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
22. Germany Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
23. Germany Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
24. Rest of Europe Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
25. Rest of Europe Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
26. Rest of Europe Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
27. Asia Pacific Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
28. Asia Pacific Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
29. Asia Pacific Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
30. China Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
31. China Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
32. China Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
33. Japan Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
34. Japan Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
35. Japan Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
36. India Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
37. India Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
38. India Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
39. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
40. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
41. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
42. Latin America Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
43. Latin America Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
44. Latin America Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
45. Brazil Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
46. Brazil Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
47. Brazil Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
48. Rest of Latin America Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
49. Rest of Latin America Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
50. Rest of Latin  America Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
51. The Middle East and Africa Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
52. The Middle East and Africa Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
53. The Middle East and Africa Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
54. Saudi Arabia Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
55. Saudi Arabia Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
56. Saudi Arabia Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
57. South Africa Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
58. South Africa Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
59. South Africa Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By End-User  ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By Application  ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By Product  ,2018–2028(USD Billion)

 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Humungous use of stem cells for treating myriad kind of ailments will steer growth of stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to therapeutic potential of stem cell-based products, and favorable laws supporting stem cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over assessment period. Rise in research activities in pharma & biotech industries will provide impetus to stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.

Furthermore, delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency and hence massive acceptance of risk-based model in pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for stem cell manufacturing industry over the years to come.  

According to Zion market research report, the global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size. Rise in cell treatment and gene therapies in the sub-continent will boost production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for growth of stem cell manufacturing business in sub-continent of North America. Presence of major participants in countries such as the U.S. and Canada will further enlarge regional market scope in upcoming years.  

 

 

The key market participants include Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.

Key applications of stem cell manufacturing include cancerous tissues, genetic disorders, degenerative ailments, and hematopoietic diseases. It also provides impetus to genomic testing activities and facilitates research in personalized medicine sector.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed